{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:56:14Z","timestamp":1781646974871,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR133118"],"award-info":[{"award-number":["NIHR133118"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The use of stimulants, such as crack-cocaine, is a global public health concern. Crack-cocaine use is increasing in the UK, but available data is focused on those who inject or also use opioids. To address this gap, characteristics of people using crack-cocaine in England, including respiratory problems among those who smoke, and variation in these by gender are described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults self-reporting crack-cocaine use in the past 28\u00a0days, recruited by specialist services and peer networks in six sites during 2023, completed a self-report survey about demographic characteristics, drug use, crack use practices, health problems and service use. Bivariable analyses and logistic regression were used to explore gender-related differences in crack-cocaine use and crack-related respiratory problems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The participants\u2019 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009731) median age was 42\u00a0years and 71% were men. Overall, 54% were stably housed, 71% had ever been imprisoned and 28% reported emergency department attendance in past 6\u00a0months. In the past 28\u00a0days, 99% had smoked crack-cocaine (44% shared pipes), with 30% injecting crack. Poly-sedative use was common including heroin (78%), pregabalin\/gabapentin (41%), and benzodiazepines (28%), with 62% receiving opioid substitution therapy. Use of drugs normally smoked was common (90% tobacco, 62% cannabis and 25% spice). Women reported less polydrug use but more often vaped nicotine. Crack-related respiratory symptoms among those smoking crack were reported by 67% of women and 58% of men. In both men and women these symptoms were associated with increasing time since first crack-cocaine use and pregabalin\/gabapentin use. In men they were also associated with food insecurity; smoking tobacco; temporary employment; and use in abandoned buildings or at friend\u2019s place; reduced odds were associated with current heroin use and using with a close friend. Among women, having a respiratory symptom was also associated with sharing pipes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Respiratory health problems are common among those smoking crack-cocaine, particularly among women. In combination with high poly-sedative use, this poses a mortality risk from respiratory depression. UK service provision is focused on prevention of opiate and injection-related risks. Services for people who use crack-cocaine and low-threshold respiratory care pathways require prioritisation to reduce avoidable morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-27073-1","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:16:27Z","timestamp":1775088987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Crack-cocaine use practices, harms and respiratory problems: an analysis of gender differences using data from a cross-sectional survey in England"],"prefix":"10.1186","volume":"26","author":[{"given":"Vivian D.","family":"Hope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlynne","family":"McGaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit D.","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SIPP Project Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Busza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedona","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Guinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedomir","family":"Vuckovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Piot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoba","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Furlong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"27073_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.drugalcdep.2017.08.036","volume":"180","author":"AJ Butler","year":"2017","unstructured":"Butler AJ, Rehm J, Fischer B. Health outcomes associated with crack-cocaine use: systematic review and meta-analyses. Drug Alcohol Depend. 2017;180:401\u201316.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"27073_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF03403687","volume":"96","author":"E Haydon","year":"2005","unstructured":"Haydon E, Fischer B. Crack use as a public health problem in Canada: call for an evaluation of \u201csafer crack use kits.\u201d Can J Public Health. 2005;96(3):185\u20138.","journal-title":"Can J Public Health"},{"key":"27073_CR3","volume-title":"Increase in crack cocaine use inquiry: summary of findings","author":"Public Health England and Home Office","year":"2019","unstructured":"Public Health England and Home Office. Increase in crack cocaine use inquiry: summary of findings. London: Home Office; 2019."},{"issue":"9","key":"27073_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1503\/cmaj.082054","volume":"181","author":"K DeBeck","year":"2009","unstructured":"DeBeck K, Kerr T, Li K, Fischer B, Buxton J, Montaner J, et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. CMAJ. 2009;181(9):585\u20139.","journal-title":"CMAJ"},{"key":"27073_CR5","unstructured":"Cocaine and crack drug profile. Drugs profiles, European Drug Agency, Lisbon. https:\/\/www.euda.europa.eu\/publications\/drug-profiles\/cocaine_en Accessed 25\/02\/2026"},{"key":"27073_CR6","unstructured":"Substance misuse treatment for adults: statistics 2024 to 2025. Office for Health Improvement and Disparities. 4 December 2025https:\/\/www.gov.uk\/government\/statistics\/substance-misuse-treatment-for-adults-statistics-2024-to-2025"},{"key":"27073_CR7","volume-title":"European Drug Report 2020: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2020","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2020: Trends and Developments. Lisbon: EMCDDA; 2020."},{"key":"27073_CR8","unstructured":"Office for Health Improvement and Disparities and UK Health Security Agency. Opiate and crack cocaine use: prevalence estimates. London, UK. 24 October 2023. Retrieved from: https:\/\/www.gov.uk\/government\/publications\/opiate-and-crack-cocaine-use-prevalence-estimates"},{"key":"27073_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102829","volume":"83","author":"M Harris","year":"2020","unstructured":"Harris M. An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom. Int J Drug Policy. 2020;83:102829. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102829.","journal-title":"Int J Drug Policy"},{"key":"27073_CR10","unstructured":"National Drug and Alcohol Treatment Monitoring System Data Set. NHS England, UK; 11 January 2024. https:\/\/standards.nhs.uk\/published-standards\/national-drug-and-alcohol-treatment-monitoring-system-data-set"},{"issue":"11","key":"27073_CR11","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/j.1360-0443.2005.01244.x","volume":"100","author":"VD Hope","year":"2005","unstructured":"Hope VD, Hickman M, Tilling K. Capturing crack cocaine use: estimating the prevalence of crack cocaine use in London using capture-recapture with covariates. Addiction. 2005;100(11):1701\u20138.","journal-title":"Addiction"},{"key":"27073_CR12","unstructured":"UKHSA. UAM survey of HIV and viral hepatitis among PWID, data to end of 2022. London: UKHSA, January 2024."},{"key":"27073_CR13","volume-title":"Estimates of the Prevalence of Opiate Use and\/or Crack Cocaine Use, 2016\/17: Sweep 123 report","author":"G Hay","year":"2019","unstructured":"Hay G. Estimates of the Prevalence of Opiate Use and\/or Crack Cocaine Use, 2016\/17: Sweep 123 report. Public Health England: Liverpool John Moores University; 2019."},{"key":"27073_CR14","unstructured":"Drug treatment activity in England 2012\u201313. Public Health England. November 2013. https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20170807160711\/http:\/\/www.nta.nhs.uk\/statistics.aspx"},{"issue":"11","key":"27073_CR15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","volume":"106","author":"KM Turner","year":"2011","unstructured":"Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978\u201388.","journal-title":"Addiction"},{"issue":"6","key":"27073_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4103\/IJPSYM.IJPSYM_61_17","volume":"39","author":"S Mohapatra","year":"2017","unstructured":"Mohapatra S, Nayak MR, Dash M. A clinical study of opioid substitution therapy in a tertiary care center of Eastern India. Indian J Psychol Med. 2017;39(6):756\u20139.","journal-title":"Indian J Psychol Med"},{"issue":"9","key":"27073_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo Jr","year":"2021","unstructured":"Santo T Jr, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatr. 2021;78(9):979\u201393. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0976.","journal-title":"JAMA Psychiatr"},{"key":"27073_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drugalcdep.2015.10.009","volume":"157","author":"B Nosyk","year":"2015","unstructured":"Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, et al. Short term health-related quality of life improvement during opioid agonist treatment. Drug Alcohol Depend. 2015;157:121\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.10.009.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"27073_CR19","doi-asserted-by":"publisher","first-page":"e1004049","DOI":"10.1371\/journal.pmed.1004049","volume":"19","author":"TD Brothers","year":"2022","unstructured":"Brothers TD, Lewer D, Jones N, Colledge-Frisby S, Farrell M, Hickman M, et al. Opioid agonist treatment and risk of death or rehospitalization following injection drug use\u2013associated bacterial and fungal infections: a cohort study in New South Wales, Australia. PLoS Med. 2022;19(7):e1004049. https:\/\/doi.org\/10.1371\/journal.pmed.1004049.","journal-title":"PLoS Med"},{"issue":"3","key":"27073_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/add.14012","volume":"113","author":"L Platt","year":"2018","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction. 2018;113(3):545\u201363.","journal-title":"Addiction"},{"key":"27073_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.drugalcdep.2017.01.020","volume":"174","author":"K Dunleavy","year":"2017","unstructured":"Dunleavy K, Munro A, Roy K, Hutchinson S, Palmateer N, Knox T, et al. Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs. Drug Alcohol Depend. 2017;174:91\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.020.","journal-title":"Drug Alcohol Depend"},{"key":"27073_CR22","unstructured":"Independent Expert Working Group: Drug misuse and dependence: UK guidelines on clinical management. 2017 London: Department of Health. https:\/\/www.gov.uk\/government\/publications\/drug-misuse-and-dependence-uk-guidelines-on-clinical-management"},{"key":"27073_CR23","unstructured":"Public health guideline: Needle and syringe programmes. National Institute for Health and Care Excellence (NICE), UK. Reference number: PH52Published: 26 March 2014 https:\/\/www.nice.org.uk\/guidance\/ph52"},{"key":"27073_CR24","unstructured":"Misuse of Drugs Act. 1971. HMSO: London, UK, 1971."},{"issue":"2","key":"27073_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/lgbt.2014.0116","volume":"2","author":"J Iversen","year":"2015","unstructured":"Iversen J, Dolan K, Ezard N, Maher L. HIV and hepatitis C virus infection and risk behaviors among heterosexual, bisexual, and lesbian women who inject drugs in Australia. LGBT Health. 2015;2(2):127\u201334. https:\/\/doi.org\/10.1089\/lgbt.2014.0116.","journal-title":"LGBT Health"},{"key":"27073_CR26","doi-asserted-by":"publisher","first-page":"102596","DOI":"10.1016\/j.eclinm.2024.102596","volume":"72","author":"A Levinsson","year":"2024","unstructured":"Levinsson A, Zolopa C, Vakili F, Udhesister S, Kronfli N, Maheu-Giroux M, et al. Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis. EClinicalMedicine. 2024;72:102596. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102596.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"27073_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/1471-2458-14-440","volume":"14","author":"L Gjersing","year":"2014","unstructured":"Gjersing L, Bretteville-Jensen AL. Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users. BMC Public Health. 2014;14(1):440. https:\/\/doi.org\/10.1186\/1471-2458-14-440.","journal-title":"BMC Public Health"},{"key":"27073_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","volume":"171","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39\u201349. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.029.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"27073_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32\u201351. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03140.x.","journal-title":"Addiction"},{"issue":"3","key":"27073_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.17730\/humo.63.3.h1phxbhrb7m4mlv0","volume":"63","author":"P Bourgois","year":"2004","unstructured":"Bourgois P, Prince B, Moss A. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Hum Organ. 2004;63(3):253\u201364. https:\/\/doi.org\/10.17730\/humo.63.3.h1phxbhrb7m4mlv0.","journal-title":"Hum Organ"},{"key":"27073_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.drugalcdep.2015.05.023.","volume":"153","author":"ED Riley","year":"2015","unstructured":"Riley ED, Shumway M, Knight KR, Guzman D, Cohen J, Weiser SD. Risk factors for stimulant use among homeless and unstably housed adult women. Drug Alcohol Depend. 2015;153:173\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.05.023.","journal-title":"Drug Alcohol Depend"},{"key":"27073_CR32","doi-asserted-by":"publisher","first-page":"109085","DOI":"10.1016\/j.drugalcdep.2021.109085","volume":"228","author":"T Davy-Mendez","year":"2021","unstructured":"Davy-Mendez T, Vittinghoff E, Dilworth SE, Suen LW, Braun C, Coffin PO, et al. Non-fatal stimulant overdose among homeless and unstably housed women in San Francisco, California. Drug Alcohol Depend. 2021;228:109085. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109085.","journal-title":"Drug Alcohol Depend"},{"issue":"4 Suppl 3","key":"27073_CR33","doi-asserted-by":"publisher","first-page":"20877","DOI":"10.7448\/IAS.19.4.20877","volume":"19","author":"K Lunze","year":"2016","unstructured":"Lunze K, Raj A, Cheng DM, Quinn EK, Lunze FI, Liebschutz JM, et al. Sexual violence from police and HIV risk behaviours among HIV-positive women who inject drugs in St. Petersburg, Russia - a mixed methods study. J Int AIDS Soc. 2016;19(4 Suppl 3):20877. https:\/\/doi.org\/10.7448\/IAS.19.4.20877.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"27073_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12888-017-1569-7","volume":"17","author":"RA Guimar\u00e3es","year":"2017","unstructured":"Guimar\u00e3es RA, de Oliveira Landgraf Castro V, do Valle Leone de Oliveira SM, Stabile AC, Motta-Castro ARC, Dos Santos Carneiro MA, et al. Gender differences in patterns of drug use and sexual risky behaviour among crack cocaine users in Central Brazil. BMC Psychiatry. 2017;17(1):412. https:\/\/doi.org\/10.1186\/s12888-017-1569-7.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"27073_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12939-014-0070-x","volume":"13","author":"N Bertoni","year":"2014","unstructured":"Bertoni N, Burnett C, Cruz MS, Andrade T, Bastos FI, Leal E, et al. Exploring sex differences in drug use, health and service use characteristics among young urban crack users in Brazil. Int J Equity Health. 2014;13(1):70. https:\/\/doi.org\/10.1186\/s12939-014-0070-x.","journal-title":"Int J Equity Health"},{"issue":"1\u20132","key":"27073_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1300\/J013v27n01_11","volume":"27","author":"S Tortu","year":"1998","unstructured":"Tortu S, Goldstein M, Deren S, Beardsley M, Hamid R, Ziek K. Urban crack users: gender differences in drug use, HIV risk and health status. Women Health. 1998;27(1\u20132):177\u201389. https:\/\/doi.org\/10.1300\/J013v27n01_11.","journal-title":"Women Health"},{"issue":"3","key":"27073_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/dar.12180","volume":"34","author":"T Cheng","year":"2015","unstructured":"Cheng T, Wood E, Nguyen P, Montaner J, Kerr T, DeBeck K. Crack pipe sharing among street\u2010involved youth in a Canadian setting. Drug Alcohol Rev. 2015;34(3):259\u201366.","journal-title":"Drug Alcohol Rev"},{"key":"27073_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-597X-6-34","volume":"6","author":"L Ti","year":"2011","unstructured":"Ti L, Buxton J, Wood E, Zhang R, Montaner J, Kerr T. Difficulty accessing crack pipes and crack pipe sharing among people who use drugs in Vancouver, Canada. Subst Abuse Treat Prev Policy. 2011;6:1\u20135.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"4","key":"27073_CR39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/10826084.2018.1528460","volume":"54","author":"J Frankeberger","year":"2019","unstructured":"Frankeberger J, Cepeda A, Natera-Rey G, Valdez A. Safer crack kits and smoking practices: effectiveness of a harm reduction intervention among active crack users in Mexico City. Subst Use Misuse. 2019;54(4):592\u2013600.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"27073_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.drugpo.2007.06.005","volume":"19","author":"L Malchy","year":"2008","unstructured":"Malchy L, Bungay V, Johnson J. Documenting practices and perceptions of \u2018safer\u2019 crack use: a Canadian pilot study. International Journal of Drug Policy. 2008;19(4):339\u201341.","journal-title":"International Journal of Drug Policy"},{"key":"27073_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4099-9","volume":"17","author":"A Prangnell","year":"2017","unstructured":"Prangnell A, Dong H, Daly P, Milloy MJ, Kerr T, Hayashi K. Declining rates of health problems associated with crack smoking during the expansion of crack pipe distribution in Vancouver, Canada. BMC Public Health. 2017;17:1\u20137.","journal-title":"BMC Public Health"},{"key":"27073_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0144-3","volume":"14","author":"C Strike","year":"2017","unstructured":"Strike C, Watson TM. Education and equipment for people who smoke crack cocaine in Canada: progress and limits. Harm Reduct J. 2017;14:1\u20137.","journal-title":"Harm Reduct J"},{"key":"27073_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-00938-7","volume":"21","author":"M Harris","year":"2024","unstructured":"Harris M, Scott J, Hope V, Busza J, Sweeney S, Preston A, et al. Safe inhalation pipe provision (SIPP): protocol for a mixed-method evaluation of an intervention to improve health outcomes and service engagement among people who use crack cocaine in England. Harm Reduct J. 2024;21:19. https:\/\/doi.org\/10.1186\/s12954-024-00938-7.","journal-title":"Harm Reduct J"},{"issue":"3","key":"27073_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.drugpo.2007.02.008","volume":"19","author":"L Leonard","year":"2008","unstructured":"Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J. \u201cI inject less as I have easier access to pipes\u201d: injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. Int J Drug Policy. 2008;19(3):255\u201364.","journal-title":"Int J Drug Policy"},{"key":"27073_CR45","doi-asserted-by":"crossref","unstructured":"Boyd S, Murray D, Snap, MacPherson D. Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver. Harm Reduct J. 2017;14:1\u20134.","DOI":"10.1186\/s12954-017-0152-3"},{"issue":"3","key":"27073_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253\u201363. https:\/\/doi.org\/10.1016\/s0376-8716(98)00028-3.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"27073_CR47","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1046\/j.1360-0443.1995.90810978.x","volume":"90","author":"MF Goldstein","year":"1995","unstructured":"Goldstein MF, Friedman SR, Neaigus A, Jose B, Ildefonso G, Curtis R. Self-reports of HIV risk behavior by injecting drug users: are they reliable? Addiction. 1995;90(8):1097\u2013104. https:\/\/doi.org\/10.1046\/j.1360-0443.1995.90810978.x.","journal-title":"Addiction"},{"key":"27073_CR48","unstructured":"European Union Drugs Agency (2025), European Drug Report 2025: Trends and Developments, Lisbon. ISBN: 978\u201392\u20139408\u2013074\u20135 https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2025_en"},{"issue":"1","key":"27073_CR49","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/dar.13979","volume":"44","author":"KL Rock","year":"2025","unstructured":"Rock KL, Frinculescu A, Shine T, Kalk NJ, Copeland CS. Impact of \u201cstreet\u201d benzodiazepines on drug-related deaths in England, Wales and Northern Ireland. Drug Alcohol Rev. 2025;44(1):355\u201365. https:\/\/doi.org\/10.1111\/dar.13979.","journal-title":"Drug Alcohol Rev"},{"key":"27073_CR50","doi-asserted-by":"publisher","first-page":"e1002965","DOI":"10.1371\/journal.pmed.1002965","volume":"16","author":"J Macleod","year":"2019","unstructured":"Macleod J, Steer C, Tilling K, Cornish R, Marsden J, Millar T, et al. Prescription of benzodiazepines, z\u2010drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records. PLoS Med. 2019;16:e1002965.","journal-title":"PLoS Med"},{"issue":"6","key":"27073_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000516165","volume":"27","author":"J van Amsterdam","year":"2021","unstructured":"van Amsterdam J, van den Brink W, Pierce M. Explaining the differences in opioid overdose deaths between Scotland and england\/wales: implications for European Opioid policies. Eur Addict Res. 2021;27(6):399\u2013412.","journal-title":"Eur Addict Res"},{"key":"27073_CR52","unstructured":"US Food and Drug Administration. FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR). Drug Safety Communications, 30\/01\/2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin"},{"issue":"2","key":"27073_CR53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1378\/chest.112.2.319","volume":"112","author":"SE Fligiel","year":"1997","unstructured":"Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and\/or tobacco. Chest. 1997;112(2):319\u201326. https:\/\/doi.org\/10.1378\/chest.112.2.319.","journal-title":"Chest"},{"issue":"8","key":"27073_CR54","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1046\/j.1360-0443.2002.00169.x","volume":"97","author":"DR Taylor","year":"2002","unstructured":"Taylor DR, Fergusson DM, Milne BJ, Horwood LJ, Moffitt TE, Sears MR, et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction. 2002;97(8):1055\u201361. https:\/\/doi.org\/10.1046\/j.1360-0443.2002.00169.x.","journal-title":"Addiction"},{"issue":"1","key":"27073_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jaip.2025.10.006","volume":"14","author":"AM Musa","year":"2026","unstructured":"Musa AM, Poole JA, Sayles HR, Rorie AC. Joint association of methamphetamine and cannabis use as risk factors for asthma exacerbations requiring hospitalization: a retrospective analysis. J Allergy Clin Immunol Pract. 2026;14(1):185\u201395. https:\/\/doi.org\/10.1016\/j.jaip.2025.10.006.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"27073_CR56","unstructured":"Harris M, Vuckovic C, McGaff C, Sharpe C, Rathod S, Piot A, Southwell M, Scott J, Hope VD, Platt L. Innovation, respiration and drug paraphernalia policy: a mixed methods study of crack pipe practice and respiratory harm in england. Under review."},{"key":"27073_CR57","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2105\/AJPH.83.10.1490-a","volume":"83","author":"JR Porter","year":"1993","unstructured":"Porter JR, Bonilla L. Crack users\u2019 cracked lips: an additional HIV risk factor. Am J Public Health. 1993;83:490\u20131.","journal-title":"Am J Public Health"},{"issue":"4","key":"27073_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/009145091304000403","volume":"40","author":"A Ivsins","year":"2013","unstructured":"Ivsins A, Roth E, Benoit C, Fischer B. Crack pipe sharing in context: how sociostructural factors shape risk practices among noninjection drug users. Contemp Drug Probl. 2013;40(4):481\u2013503. https:\/\/doi.org\/10.1177\/009145091304000403.","journal-title":"Contemp Drug Probl"},{"key":"27073_CR59","unstructured":"Asthma-is-worse-for-women. Asthma + Lung UK, London. April 2022. https:\/\/www.asthmaandlung.org.uk\/sites\/default\/files\/2023-02\/asthma-is-worse-for-women-report-1.pdf"},{"issue":"1","key":"27073_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1164\/rccm.201409-1740PP.","volume":"192","author":"KE Pinkerton","year":"2015","unstructured":"Pinkerton KE, Harbaugh M, Han MK, Jourdan Le Saux C, Van Winkle LS, Martin WJ 2nd, et al. Women and lung disease. Sex differences and global health disparities. Am J Respir Crit Care Med. 2015;192(1):11\u20136. https:\/\/doi.org\/10.1164\/rccm.201409-1740PP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"27073_CR61","doi-asserted-by":"publisher","first-page":"bqab254","DOI":"10.1210\/endocr\/bqab254.","volume":"163","author":"JM Siegfried","year":"2022","unstructured":"Siegfried JM. Sex and gender differences in lung cancer and chronic obstructive lung disease. Endocrinology. 2022;163(2):bqab254. https:\/\/doi.org\/10.1210\/endocr\/bqab254.","journal-title":"Endocrinology"},{"issue":"6","key":"27073_CR62","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/thx.2009.122002","volume":"65","author":"IC S\u00f8rheim","year":"2010","unstructured":"S\u00f8rheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010;65(6):480\u20135. https:\/\/doi.org\/10.1136\/thx.2009.122002.","journal-title":"Thorax"},{"issue":"2","key":"27073_CR63","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1124\/pharmrev.121.000361","volume":"75","author":"EB Towers","year":"2023","unstructured":"Towers EB, Williams IL, Qillawala EI, Rissman EF, Lynch WJ. Sex\/gender differences in the time-course for the development of substance use disorder: a focus on the telescoping effect. Pharmacol Rev. 2023;75(2):217\u201349. https:\/\/doi.org\/10.1124\/pharmrev.121.000361.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"27073_CR64","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.drugpo.2009.12.008","volume":"21","author":"V Bungay","year":"2010","unstructured":"Bungay V, Johnson JL, Varcoe C, Boyd S. Women\u2019s health and use of crack cocaine in context: structural and \u201ceveryday\u201d violence. Int J Drug Policy. 2010;21(4):321\u20139. https:\/\/doi.org\/10.1016\/j.drugpo.2009.12.008.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"27073_CR65","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.socscimed.2007.11.008","volume":"66","author":"K Shannon","year":"2008","unstructured":"Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911\u201321. https:\/\/doi.org\/10.1016\/j.socscimed.2007.11.008.","journal-title":"Soc Sci Med"},{"issue":"5","key":"27073_CR66","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/fampra\/cmaa040","volume":"19","author":"JM Groeneveld","year":"2020","unstructured":"Groeneveld JM, Ballering AV, van Boven K, Akkermans RP, Olde Hartman TC, Uijen AA. Sex differences in incidence of respiratory symptoms and management by general practitioners. Fam Pract. 2020;19(5):631\u20136. https:\/\/doi.org\/10.1093\/fampra\/cmaa040.","journal-title":"Fam Pract"},{"issue":"1","key":"27073_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2010-0031","volume":"33","author":"EA Townsend","year":"2012","unstructured":"Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev. 2012;33(1):1\u201347. https:\/\/doi.org\/10.1210\/er.2010-0031.","journal-title":"Endocr Rev"},{"issue":"8","key":"27073_CR68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tem.2007.08.003","volume":"18","author":"MA Carey","year":"2007","unstructured":"Carey MA, Card JW, Voltz JW, Arbes SJ Jr, Germolec DR, Korach KS, et al. It\u2019s all about sex: gender, lung development and lung disease. Trends Endocrinol Metab. 2007;18(8):308\u201313. https:\/\/doi.org\/10.1016\/j.tem.2007.08.003.","journal-title":"Trends Endocrinol Metab"},{"key":"27073_CR69","doi-asserted-by":"publisher","first-page":"105165","DOI":"10.1016\/j.drugpo.2026.105165","volume":"149","author":"C Sharpe","year":"2026","unstructured":"Sharpe C, Busza J, Vuckovic C, Scott J, Hope V, Southwell M, et al. Pipes as an engagement tool: qualitative findings from a crack equipment and harm reduction training intervention in England. Int J Drug Policy. 2026;149:105165. https:\/\/doi.org\/10.1016\/j.drugpo.2026.105165.","journal-title":"Int J Drug Policy"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27073-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:21:29Z","timestamp":1781644889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27073-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27073"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27073-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols and research implements were approved by the London School of Hygiene and Tropical Medicine\u2019s Research Ethics Committee (ref: 28102). All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JS is paid by the College of Mental Health Pharmacy twice a year for 1.5 hours CPD teaching; work for Turning Point (a UK provider of service to people who use drugs); and is co-investigator on a grant funded by Gilead.VH noneLP noneSR noneCM noneCS noneMH none","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1540"}}